1. Organization and principal activities

Principal Activities:

Meihua International Medical Technologies Co., Ltd. (“Meihua” or “the Company”) was incorporated on November 10, 2020 in the Cayman Islands. It is a holding company with no operations. Meihua, through its subsidiaries (together, “the Group”) produces and sells medical consumables in People’s Republic of China (“PRC” or “China”).

As of December 31, 2025, the Company’s subsidiaries are as follows: 

Kang Fu was incorporated on October 13, 2015 with a registered capital of HKD 63,254,200 ($8,109,513). Kang Fu is a holding company with no operations. Yangzhou Huada, Jiangsu Yada and Jiangsu Huadong are directly or indirectly 100% owned by Kang Fu for all the periods presented.

Yangzhou Huada is a subsidiary wholly owned by Kang Fu and established in Yangzhou, China on December 24, 2001 with a registered capital of $602,400. On March 3, 2022, the registered capital was increased to $50,602,400.

Jiangsu Yada is a subsidiary wholly owned by Yangzhou Huada and was established in Yangzhou, China on December 5, 1991 with a registered capital of RMB51,390,000.

Jiangsu Huadong is a subsidiary wholly owned by Jiangsu Yada and was established in Yangzhou, China on November 18, 2000 with a registered capital of RMB50,000,000.

Those three subsidiaries primarily manufacture and sell Class I, II and III disposable medical devices under the Company’s own brands, and distribute Class I, II and III disposable medical devices sourced from other manufacturers to our domestic and overseas customers.

Hainan Ruiying is a subsidiary 51% owned by Jiangsu Huadong and established in Hainan, China on October 25, 2023 with a registered capital of RMB10,000,000. Hainan Ruiying has not commenced its intended operation for the year ended December 31, 2024.

Meihua Future is a subsidiary wholly owned by Meihua and was established in New York, United States on July 31, 2025 with a registered capital of $5,000.